Vira-a

   
Google
 
Web NewDrugInformation.com

Vira-a


Drug - Vira-a
The trade name of the product as shown on the labeling.

Dosage - INJECTABLE; INJECTION
The product dosage form and route separated by a semi-colon.

Active Ingredient(s) - Vidarabine
Multiple ingredients are in alphabetical order.

Strength - EQ 187.4MG BASE/ML
The potency of the active ingredient(s), Vidarabine. May repeat for multiple part products.

Applicant - PARKEDALE
The firm name holding legal responsibility for Vira-a. The firm name is condensed to a maximum twenty character unique string.

New Drug Application (NDA) Number - 050523
The FDA assigned number to Vira-a. Format is nnnnnn.

Product Number - 001
The FDA assigned number to identify Vira-a. Each strength is a separate product. May repeat for multiple part products. Format is nnn.

Therapeutic Equivalence (TE) Code -
The TE Code indicates the therapeutic equivalence rating of generic to innovator Rx products.

Approval Date - Approved Prior to Jan 1, 1982
The date Vira-a was approved as stated in the FDA approval letter to the applicant. The format is Mmm dd, yyyy. Products approved prior to the January 1, 1982 contain the phrase: "Approved prior to Jan 1, 1982".

Reference Listed Drug (RLD) - No
The pioneer or innovator of Vira-a. The RLD identifies the product Abbreviated New Drug Applications (ANDA) use as a reference. Format is Yes or No.

Type - DISCN
The group or category of approved drugs Vira-a is in. Format is RX, OTC, DISCN.

Applicant Full Name - Parkedale Pharmaceuticals Inc
The full name of the firm holding legal responsibility for the new application of Vira-a.

Vira-a